🇺🇸 FDA
Pipeline program

Chinese Herb

COVID Acute study

Phase 2 small_molecule active

Quick answer

Chinese Herb for COVID-19 is a Phase 2 program (small_molecule) at Chinese University of Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Chinese University of Hong Kong
Indication
COVID-19
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials